Navigation Links
Health Market Science Launches Clinical Investigators(TM)
Date:7/17/2008

The Only All-Inclusive Tool That Clinical Recruiters Need to Achieve Their

Trial Site Recruitment Goals

KING OF PRUSSIA, Pa., July 17 /PRNewswire/ -- Health Market Science, Inc., a leading source of healthcare provider data and analytics solutions in the United States, announced today the launch of Clinical Investigators, their latest innovation for clinical site recruitment. Clinical Investigators dramatically reduces the time needed by pharmaceutical companies and contract research organizations (CRO's) to recruit physicians for clinical trials by providing instant online access to one of the industry's most comprehensive, up-to-date national databases of physician reference data, clinical trial experience, and claims volume rankings.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071026/NEF019LOGO )

"With more than 80% of clinical trials experiencing delays, the industry is looking for insight into how trial site selection can become a more effective, efficient and repeatable process," says Zach Henderson, Vice President, Marketing and Product Development at Health Market Science. "Clinical Investigators provides our clients a competitive advantage by accelerating the identification and recruitment of the best investigators for their trial protocol.

"Clinical operations executives continue to face the increased pressures of heightened regulatory scrutiny of trial results, soaring R&D costs, and the need to accelerate the time-to-market for new drugs. Clinical Investigators allows users to immediately begin their planning for site recruitment or aid them in the implementation of an effective rescue plan to get their trial back on target as well as reduce additional costs and time delays.

Clinical Investigators links an intuitive web-based user interface with a national, comprehensive database of trial experience detail, claims data, and Health Market Science's Provider Master File. With over 4.5 million individual providers and 1.0 million healthcare organizations, the Health Market Science Provider Master File is a trusted source of physician site detail and affiliations.

About Health Market Science

Health Market Science is the leading source for healthcare provider data and advanced analytics in the United States. Health Market Science has developed unique technology and expertise to continuously acquire, analyze, and integrate over 2,500 distinct data sources to create and maintain the single most comprehensive and accurate source of healthcare provider information available today. The HMS MasterFile(TM) includes detailed reference information for over 4.5 million individual providers and 1.0 million healthcare organizations.

Serving all segments of healthcare, including pharmaceutical manufacturers, biotechs, device manufacturers, payers, providers, and pharmacy chains, Health Market Science is the only company that offers claims information, advanced analytics and the reference data that powers them. This unique combination results in dramatically higher data accuracy and reliability, enabling our customers to increase revenues, drive operational efficiencies, achieve regulatory compliance, and maximize market opportunities.

Recognized on the Inc. 500 as one of the fastest growing private companies in the United States and 10th on Deloitte's Technology Fast 50 Program for Greater Philadelphia, our more than 200 customers include 20 of the top 20 pharmaceutical manufacturers, 10 of the 15 largest device manufacturers, and 3 of the top 5 pharmacy chains. Health Market Science is a privately held company located in King of Prussia, PA. For more information, visit http://www.healthmarketscience.com. For more information on Clinical Investigators go to http://www.healthmarketscience.com/targeting/clinical-investigators.php


'/>"/>
SOURCE Health Market Science, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... DIEGO , March 27, 2017  Trovagene, Inc. ... that its Chief Executive Officer, Bill Welch , ... April 4, 2017 at 9:00 AM EDT at the ... .  Bill Welch, and Chief Scientific Officer, Mark ... with investors during the conference.   The presentation ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Human ... report to their offering. ... This report analyzes the Global market for Human Embryonic ... are provided for the period 2014 through 2022. Market data and ... The report profiles 25 companies including many key and niche players ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
Breaking Biology Technology:
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):